CDC is in negotiations with Bavarian Nordic, a biotechnology firm based in Hellerup, Denmark, to obtain 200,000 doses of the company’s two-dose mpox vaccine, Kaseya announced at a briefing on 8 August. But that’s a far cry from the 10 million doses that the Africa CDC estimates are needed to stop the current outbreak, Kaseya added. What about SIGA?
Siga signs $113M US supply contract for mpox antiviral Tpoxx ByKevin DunleavyJul 19, 2024 10:35am Siga TechnologiesmonkeypoxmpoxSmallpox The U.S. has signed on for another $113 million supply of Siga Technologies' Tpoxx, an antiviral treatment for mpox (formerly monkeypox). (Photo by YUKI IWAMURA/AFP via Getty Images) The U.S. government hasexerciseda contract option and will pay $113 million for delivery of Siga Technologies’ oral smallpox antiviral Tpoxx. The agreement builds on the deals New York City-based Siga made with the Department of Health and Human Services (HHS) the last two years for preparedness against the mpox (formerly monkeypox) virus. In July of last year, the HHS also signed on for a $113 million supply of oral Tpoxx, plus $25 million of the medicine’s intravenous formulation. Last year, in addition to the U.S., Siga had 15 international customers, CEO Diem Nguyen said in a release.
Orasure @$4 As soon as it gets above $5, the PM's can buy it. $5 is a magic number for stocks like that. It plays into whatever that tl/dr article above about outbreaks in Africa too. There's your stock of the day. Now I'm gonna cash out my 40% return before the Q's drop back.
I got you in a tad higher when you recommended it as a competition for NTRA. It's our only public game-- the public here is dumbstruck and hamstrung...